How Much Did Demetrix Raise?
Funding & Key Investors

Demetrix, a Berkeley-based biotechnology firm, has successfully secured a total of $61M in capital to accelerate its mission of revolutionizing the production of rare, high-purity cannabinoids. The company recently finalized a major strategic investment of $50M, marking a significant milestone in its trajectory toward scaling commercial operations. This infusion of capital underscores investor confidence in the firm's proprietary fermentation technology and its potential to disrupt both pharmaceutical and consumer wellness markets.

The funding history reflects a steady progression from its initial seed phase to its current enterprise-level scaling. By leveraging these resources, Demetrix is positioned to bridge the gap between complex scientific research and large-scale industrial production, ensuring that high-quality, science-backed ingredients are accessible for diverse commercial applications.

What is Demetrix?

Demetrix
ManufacturingPharmaceuticalsBusiness Services

Founded in 2015, Demetrix operates at the intersection of synthetic biology and consumer health. The company specializes in the fermentation-based production of rare cannabinoids, a process that offers a more sustainable and consistent alternative to traditional extraction methods. By assembling a multidisciplinary team of experts in R&D, regulatory affairs, and commercialization, Demetrix has established itself as a leader in the biotechnology sector. Their market position is defined by a commitment to high-purity standards, enabling them to serve as a critical supplier for pharmaceutical developers and wellness brands seeking reliable, science-driven ingredients.

How much funding has Demetrix raised?

Demetrix has raised a total of $61M across 2 funding rounds:

2019

Angel/Seed

$11M

Series A

$50M

Angel/Seed (2019): $11M with participation from Horizons Ventures

Series A (2019): $50M led by Tuatara Capital and Horizons Ventures

Key Investors in Demetrix

Tuatara Capital

Tuatara Capital is a private equity firm dedicated to supporting innovative entrepreneurs by providing foundational partnerships and strategic guidance throughout the business lifecycle.

Horizons Ventures

Horizons Ventures is a prominent venture capital firm with over two decades of experience helping entrepreneurs transform startup ventures into successful, market-leading companies through active involvement and equity financing.

What's next for Demetrix?

With the recent influx of capital, Demetrix is poised to transition from its research-heavy foundation into a phase of aggressive commercial expansion. The strategic focus will likely center on optimizing production yields through their fermentation platform and navigating the complex regulatory landscape for cannabinoid-based products. As the company scales, it will prioritize the commercialization of its pipeline, aiming to secure long-term partnerships with major pharmaceutical and consumer goods entities. This growth phase is critical for establishing Demetrix as the primary infrastructure provider for the next generation of health and wellness solutions.

See full Demetrix company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Health & Nutrition ProductsManufacturingRetailVitamins, Supplements & Health Stores
Building MaterialsManufacturingIndustrial Machinery & Equipment
Industrial Machinery & EquipmentManufacturing
Industrial Machinery & EquipmentManufacturing

Frequently Asked Questions Regarding Demetrix Financial Insights

What are the most recent funding rounds that Demetrix has completed, and what were the funding rounds?
Demetrix has recently completed 2 funding rounds: Series A on Jul 11, 2019, Angel/Seed on Mar 4, 2019.
What is the total amount of funding Demetrix has raised to date?
Demetrix has raised a total of $61M in funding to date.
How many funding rounds has Demetrix completed?
Demetrix has completed 2 funding rounds.
How much funding did Demetrix raise in its most recent funding round?
Demetrix raised $50M in its most recent funding round.
Who are the lead investors in Demetrix's latest funding round?
The lead investor in Demetrix's latest funding round was Tuatara Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Demetrix's history?
The largest funding round in Demetrix's history was $50M.
See more information about Demetrix